Literature DB >> 8856734

The effects of dextromethorphan on kainic acid-induced seizures in the rat.

H C Kim1, K R Pennypacker, G Bing, D Bronstein, M K McMillian, J S Hong.   

Abstract

Several studies have shown that dextromethorphan (DM) has both anticonvulsant and proconvulsant effects depending on the animal model. In this study, we examined the effects of DM on three parameters associated with kainic acid (KA)-induced seizures: cell loss in the hippocampus, increased AP-1 DNA binding activity and increased c-Jun and fos-related antigen (FRA) expression. KA administration (8 mg/kg, ip) produced robust behavioral convulsions lasting 4-6 hr. Pretreatment with DM (12.5-75 mg/kg, po) 15 min before KA injections reduced the seizures as well as mortality in a dose-dependent manner. Histological studies revealed a severe loss of cells in the CA1 and CA3 fields of the hippocampus in KA-treated rats. DM pretreatment also reduced this cell loss in a dose-dependent fashion. Biochemical studies showed that DM pretreatment also attenuated the KA-induced increase of AP-1 binding activity and c-Jun/FRA expression in the hippocampus. These results indicate that DM is an effective antagonist of KA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856734

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  9 in total

1.  The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.

Authors:  Eun-Joo Shin; Seung-Yeol Nah; Won-Ki Kim; Kwang Ho Ko; Wang-Kee Jhoo; Yong-Kwang Lim; Joo Young Cha; Chieh-Fu Chen; Hyoung-Chun Kim
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 2.  Neuropsychopharmacological understanding for therapeutic application of morphinans.

Authors:  Eun-Joo Shin; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

3.  Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.

Authors:  Olga V Chechneva; Florian Mayrhofer; Daniel J Daugherty; David E Pleasure; Jau-Shyong Hong; Wenbin Deng
Journal:  Neurobiol Dis       Date:  2011-06-24       Impact factor: 5.996

4.  PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis.

Authors:  Hai-Quyen Tran; Youngho Lee; Eun-Joo Shin; Choon-Gon Jang; Ji Hoon Jeong; Akihiro Mouri; Kuniaki Saito; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2018-02-22       Impact factor: 5.590

5.  Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells.

Authors:  D Tian; V Litvak; S Lev
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

6.  Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan.

Authors:  Xiaofeng Xu; Bin Zhang; Kaili Lu; Jiangshan Deng; Fei Zhao; Bing-Qiao Zhao; Yuwu Zhao
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

7.  Exposure to extremely low frequency magnetic fields induces fos-related antigen-immunoreactivity via activation of dopaminergic d1 receptor.

Authors:  Eun-Joo Shin; Xuan-Khanh Thi Nguyen; Thuy-Ty Lan Nguyen; Diem-Thu Pham; Hyoung-Chun Kim
Journal:  Exp Neurobiol       Date:  2011-09-20       Impact factor: 3.261

Review 8.  Neuroprotective effects of psychotropic drugs in Huntington's disease.

Authors:  Edward C Lauterbach
Journal:  Int J Mol Sci       Date:  2013-11-15       Impact factor: 5.923

9.  Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT.

Authors:  Kuo-Hsing Ma; Tsung-Ta Liu; Shao-Ju Weng; Chien-Fu F Chen; Yuahn-Sieh Huang; Sheau-Huei Chueh; Mei-Hsiu Liao; Kang-Wei Chang; Chi-Chang Sung; Te-Hung Hsu; Wen-Sheng Huang; Cheng-Yi Cheng
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.